Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
Resource Type
Article
Authors
Jansen, Fenna M ; Linschoten, Reinier C A van ; Kievit, Wietske ; Smits, Lisa J T ; Pauwels, Renske W M ; Jong, Dirk J de ; Vries, Annemarie C de ; Boekema, Paul J ; West, Rachel L ; Bodelier, Alexander G L ; Gisbertz, Ingrid A M ; Wolfhagen, Frank H J ; Römkens, Tessa E H ; Lutgens, Maurice W M D ; Bodegraven, Adriaan A van ; Oldenburg, Bas ; Pierik, Marieke J ; Russel, Maurice G V M ; Boer, Nanne K de ; Mallant-Hent, Rosalie C
Source
Journal of Crohn's & Colitis; Nov2023, Vol. 17 Issue 11, p1771-1780, 10p
Subject
Language
ISSN
18739946